TrialCancer2025

Long-term follow-up of a phase 2 study of all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia.

Wei-Ying Jen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.